Hotspot


Hematological Oncology | 2017

DOWN‐REGULATION OF MIR‐150 AND UP‐REGULATION OF ITS TARGET FOXP1 IS ASSOCIATED WITH TRANSFORMATION OF FOLLICULAR LYMPHOMA

Kateřina Musilová; Gabriela Pavlasová; Václav Šeda; Kateřina Černá; Eva Vojáčková; Jana Didi; Robert Pytlik; Vit Prochazka; Zuzana Prouzová; Lenka Zlámalíková; Heidi Mocikova; Marie Jarosova; A. Evans; Clive S. Zent; Leos Kren; Marek Trneny; Jiří Mayer; Andrea Janíková; Marek Mráz

Down-regulation of miR-150 and up-regulation of its target FOXP1 is associated with transformation of follicular lymphoma.Down-regulation of miR-150 and up-regulation of its target FOXP1 is associated with transformation of follicular lymphoma.


Blood | 2012

Microrna-34a as a marker for fludarabine resistance and impairment of p53-pathway in chronic lymphocytic leukemia

Marek Mráz; Kateřina Černá; Veronika Mayerová; Kateřina Musilová; Karla Plevová; Šárka Pavlová; Boris Tichý; Michael Doubek; Yvona Brychtová; Jitka Malčíková; Jiří Mayer; Martin Trbušek; Šárka Pospíšilová


Archive | 2017

MicroRNA induced by DNA damage response regulates the expression of FOXP1 and therapy response in CLL

Kateřina Černá; Jan Oppelt; Václav Šeda; Kateřina Musilová; Gabriela Pavlasová; Veronika Svobodová; Jiří Mayer; Šárka Pospíšilová; Marek Mráz


Archive | 2017

The identification of combinatorial therapeutic approaches with BCR inhibitors in B cell malignancies

Gabriela Pavlasová; Kateřina Musilová; Václav Šeda; Kateřina Černá; Eva Vojáčková; Veronika Svobodová; Marek Mráz


Archive | 2017

Regulation of B-cell receptor signalling in chronic lymphocytic leukaemia (CLL) microenvironment via modulation of GAB1 protein levels.

Václav Šeda; Eva Vojáčková; Tomáš Loja; Gabriela Pavlasová; Kateřina Černá; Kateřina Musilová; Veronika Svobodová; Sonali Sharma; Marek Mráz


Archive | 2017

Differential expression of microRNAs in transformation of follicular lymphoma to diffuse large B cell lymphoma

Kateřina Musilová; Gabriela Pavlasová; Václav Šeda; Eva Vojáčková; Kateřina Černá; Veronika Svobodová; Robert Pytlik; Vit Prochazka; Zuzana Prouzová; Šárka Pospíšilová; Lenka Zlámalíková; Heidi Mocikova; Lenka Kruzova; Marie Jarosova; Andrew G. Evans; Clive S. Zent; Leoš Křen; Marek Trněný; Jiří Mayer; Andrea Janíková; Marek Mráz


Archive | 2017

BCR signalling proficient chronic lymphocytic leukaemia cells are prone to rituximab mediated elimination in vivo.

Gabriela Pavlasová; Marek Borský; Veronika Svobodová; Kateřina Musilová; Kateřina Černá; Václav Šeda; Jitka Novotná; Yvona Brychtová; Michael Doubek; Šárka Pospíšilová; Jiří Mayer; Marek Mráz


Archive | 2016

Ibrutinib inhibits CD20 up-regulation on CLL B cells mediatedby the CXCR4/SDF-1 axis.

Gabriela Pavlasová; Marek Borský; Václav Šeda; Kateřina Černá; Jitka Osičková; Michael Doubek; Jiří Mayer; Raffaele Calogero; Šárka Pospíšilová; Matthew S. Davids; Jami Brown; Marek Mráz


Archive | 2016

Způsob absolutní kvantifikace exprese miRNA, zejména miR-34aa/nebo miR-150, a jeho použití v diagnostice a prognosticeB-buněčných malignit

Marek Mráz; Kateřina Černá; Šárka Pospíšilová; Jiří Mayer


Archive | 2016

MicroRNAs in the microenvironmental interactions of B cellleukemias.

Marek Mráz; Kateřina Černá; Gabriela Pavlasová; Kateřina Musilová; Václav Šeda; Jiří Mayer; Šárka Pospíšilová

Researchain Logo
Decentralizing Knowledge